• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Medicines adherence

Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence.

Status:	History
Publication date:	January 2009
Wave:	11
Process:	CG
Topic area: Mental health and behavioural conditions

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Andrew Dillon
Communications manager:	Sarita Tamber
Guidelines commissioning manager:	Sarah Willett
Guidelines coordinator:	Andrew Gyton
Patient involvement lead:	Barbara Meredith
Lead collaborating centre:	The National Collaborating Centre for Primary Care
Guidance developer contact:	Nancy Turnbull
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	06 November 2006
Consultation on draft scope with stakeholders:	30th October 2006 - 27th November 2006
Consultation on draft guideline with stakeholders:	29 July - 23 September 2008
Pre-publication check:	TBC
Publication date:	January 2009

Top

 

Project history

Date Update 2 August 2005 The remit (see link below) for this guideline was received from the Department of Health and the Welsh Assembly Government in April 2005 as part of the Institute's 11th wave work programme. See below for more information on the Institute's guideline development process. 8 September 2006 Guidelines Coordinator changed to Bijal Chandarana 30 October 2006 The draft scope (see link below) is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown. 28 November 2006 Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply. 4 December 2006 List of stakeholders updated. 7 March 2007 List of stakeholders updated. 14 June 2007 The scope (see link below) defines what aspects of care are covered by the guideline and to whom it applies. 29 July 2008 Consultation on the draft full guideline and draft NICE guideline begins today.

Top

 

Key documents

Medicines adherence: stakeholder comments 28 January 2009 Medicines adherence: list of stakeholders 18 July 2011 Medicines concordance: guideline consultation 29 July 2008 Guideline development group: members and minutes 14 April 2008 Medicines concordance: final scope 14 June 2007 Medicines adherence: consultation comments table 14 June 2007 Medicines concordance - Draft scope 30 October 2006 Medicines concordance - Scope consultation comments form 30 October 2006 Stakeholder registration 21 April 2004 National Collaborating Centre for Primary Care 02 June 2003 Medicines concordance - Remit 21 October 2002 The guideline development process - an overview for stakeholders, the public and the NHS (third edition) 25 April 2007

This page was last updated: 05 August 2011